Zhejiang Wolwo Bio-Pharmaceutical's (SHE:300357) attributable profit rose 1.2% year over year to 123 million yuan in the third quarter, according to a Thursday filing with the Shenzhen Stock Exchange.
Earnings per share at the drug company increased 1.3% year over year to 0.2350 yuan.
Operating income grew 4.7% year over year to 301 million yuan.
Shares closed 7% higher during Thursday's trading.
Price (RMB): ¥24.97, Change: ¥+1.7, Percent Change: +7.31%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments